* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Annette Vinther Heydenreich
Survey
Document related concepts
Comparative genomic hybridization wikipedia , lookup
Maurice Wilkins wikipedia , lookup
Molecular evolution wikipedia , lookup
Community fingerprinting wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Genomic library wikipedia , lookup
Agarose gel electrophoresis wikipedia , lookup
Non-coding DNA wikipedia , lookup
Molecular cloning wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Gel electrophoresis of nucleic acids wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
DNA supercoil wikipedia , lookup
Transformation (genetics) wikipedia , lookup
Cell-penetrating peptide wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Transcript
Abstract nr. F9 Ph.d.-studerende Annette Vinther Heydenreich Institut for Farmaci Studiestart 1. november 1998 Vejledere Henning Gjelstrup Kristensen og Anders Fomsgaarda Titel på forskningsprojekt Mucosal DNA Vaccine Delivery with Cationic Solid Lipid Nanospheres a Department of Virology, Statens Serum Institut, Copenhagen Genetic immunization (DNA vaccines) has the potential to both produce neutralizing antibodies (humoral immune response) and cytotoxic T-cells (cellular immune response), which is believed to be essential in viral infections like HIV. In order to stop the viral replication at the site of entry, mucosal immunity with high levels of sIgA antibodies can obtained by vaccination at the musosal sites. Efficient delivery of genetic vaccines requires a drug delivery system able to stabilize/ protect DNA against nucleases, to facilitate cellular uptake and endo/lysosomal release once taken up and to mediate cell-specific targeting. The purpose of this study is therefore to investigate Solid Lipid Nanospheres (SLN) as a particulate drug delivery system for mucosal genetic immunization. Solid Lipid Nanospheres (SLN) combine the advantages from liposomes (e.g. biocompatible compounds) and solid drug carriers as polymeric nanoparticles (e.g. prolonged circulation time, protection of the drug) without having the disadvantages of viral delivery systems. Mucosal (nasal, oral, rectal) administration of particles are taken up by the M-cells and are transported directly to the dendritic cells in the underlying immune tissue. SLN were obtained by diluting warm microemulsions (o/w) composed of different fatty acids or triglycerides (all solid at room temperature), cationic lipids, nonionic surfactants and cosurfactants in cold water. After washing the SLN by dialysis, particle size distribution and zetapotential was measured. The resulting particles were between 100 and 500 nm in size (PI~0.3) and showed zetapotentials between +10 and +35 mV at pH 7.4. Physico-chemical properties of SLN were strongly dependent on the composition. Additionally, morphology was examined by scanning electron microscopy (SEM) showing spherical particles. The DNA was either incorporated in the SLN during the preparation or complexed to the surface at different charge ratios after the preparation. The latter was having little effect on the particle size. The physical stability of the SLN-DNA complexes was dependent on the ionic strength of the solution, the loading time and the zetapotential of the particles, indicating more than an electrostatic interaction. The extracted DNA and the complexation were analyzed by agarose gel electrophoresis, showing no degradation and change in structure. The complexes were further characterized by SEM and zetapotential measurements. The SLN were able to protect the DNA against degradation by DNase I. Cytotoxicity (MTT test) and transfection efficiency were tested in vitro using pCMV-EGFP in various cell-lines (HEK 293, CPH 54A and NR6). Uptake, localization and co-localization studies were performed using the lipid soluble fluorescent dye 4,4-Difluoro1,3,5,7,8-penta-methyl-4-bora-3a,4a-diaza-s-indacene (BODIPY492/515), pGeneGrip Rhodamine/GFP and LysoTracker Red DND-99. The cells studies showed uptake of SLN and DNA in various fibroblast cell lines and in immature dendritic cells, preferentially in the cytoplasm. No transfection was observed. In the literature no correlation between in vitro and in vivo transfection is observed, and in vivo immunizations in mice are ongoing. Positive results are still to come. Conclusions. Cationic SLN may serve as potential particulate delivery systems for plasmid DNA in regard to protection of DNA and their sizes suggest an uptake by M-cells. But they have to be optimized in order to escape the lysosomes and thereby deliver DNA to the site of action.